Understanding Components of Mind-body Exercise for Physical Activity Engagement in Metabolic Syndrome
Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Feb 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to explore how different types of mind-body exercises can help people with metabolic syndrome become more active. Metabolic syndrome is a condition that includes having certain health issues like being overweight, high blood sugar, or high blood pressure. The study will involve participants completing one of four activities: a walking program, a mindful attention program, a combination of both, or no program at all. This pilot study will help researchers understand how well the program works and what participants think about it.
To join the study, participants need to be between 18 and 70 years old and have metabolic syndrome, which means they meet at least three specific health criteria. They should also be insufficiently active, meaning they don’t engage in much physical activity. Participants must have medical approval to exercise and have access to the internet for virtual sessions. Throughout the trial, participants can expect to follow one of the exercise programs and provide feedback on their experience. This study is currently recruiting, and it is open to all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Metabolic syndrome, defined as meeting 3 or more of the following criteria in the last 12 months at the time of medical record review: (a) BMI ≥ 25; (b) fasting glucose ≥ 100 \[5.6 mmol/L\] or A1C ≥ 5.7 or medications; (c) blood pressure ≥ 130 systolic or ≥ 85 diastolic or medications; (d) triglycerides ≥ 150 or 1.7 mmol/L or medications; (e) or HDL \< 40mg/ dL for men and 50mg/dL for women or medications;
- • insufficiently active, defined as a score ≤ 23 (moderate-to-strenuous units) on Godin-Shepard Leisure-Time Physical Activity Questionnaire;
- • age 18-70 years;
- • given medical clearance for moderate-intensity exercise and exercise stress testing by their primary care physician (PCP);
- • access to a device with internet and videoconferencing capabilities
- Exclusion Criteria:
- • current diagnosis of any of the following: (a) coronary artery disease or other chronic heart diseases (e.g., heart failure) in which exercise would be contraindicated or that would preclude HRV analyses (e.g., some arrhythmias); (b) any diabetes; (c) chronic obstructive pulmonary disease or other severe lung dysfunction (e.g., severe asthma); (d) severe cognitive impairment
- • \>2 self-reported classes or self-guided mindfulness or mindful movement sessions per week in past 3 months
- • self-reported inability to speak and read in English
- • current beta blocker or calcium channel blocker medication
- • uncontrolled hypertension, defined as resting blood pressure ≥ 150 systolic or ≥ 90 diastolic in the last 6 months
- • self- or physician-reported contraindications for exercise (e.g., severe balance impairment, musculoskeletal restrictions)
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center (BIDMC) is a leading academic medical center located in Boston, Massachusetts, affiliated with Harvard Medical School. Renowned for its commitment to cutting-edge research and innovation in healthcare, BIDMC fosters a collaborative environment that integrates patient care, education, and scientific investigation. The center actively sponsors clinical trials across a variety of disciplines, aiming to advance medical knowledge and improve patient outcomes. With a focus on translational medicine, BIDMC's research initiatives engage multidisciplinary teams to address complex health challenges and translate findings into effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials